An antimicrobial 10-peptide and its application
CN121824683BActive Publication Date: 2026-05-26CHONGQING UNIV OF TECH
3 Cites 0 Cited by
Patent Information
- Application Number
- CN202610270356.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-06
- Publication Date
- 2026-05-26
- Estimated Expiration
- 2046-03-06
AI Technical Summary
Technical Problem
[0002]细菌感染是常见的卫生健康问题,随着抗生素的滥用,抗生素耐药性不断上升,已出现多种抗多药耐药细菌,对全球公共卫生健康产生严重危害
Benefits of technology
[0016]本发明提供的抗菌肽对于多种致病菌具有良好的抗菌活性,该抗菌肽可通过Fmoc固相化学法合成,合成难度低,且体内抗菌活性较好。该抗菌肽对多药耐药鲍曼不动杆菌、耐碳青霉烯类铜绿假单胞菌以及标准菌株鲍曼不动杆菌、铜绿假单胞菌、肺炎克雷伯杆菌、大肠埃希菌、阴沟肠杆菌、甲氧西林耐药金黄色葡萄球菌、金黄色葡萄球菌具有广谱杀伤活性,溶血毒性低,在中低浓度(2μg/mL~32μg/mL)下细胞存活率能达到半数以上,对细胞几乎无毒害作用,稳定性好,可操作性强,成本低。
✦ Generated by Eureka AI based on patent content.
Abstract
This invention discloses an antimicrobial 10-peptide, characterized by the sequence: w-k-r-w-r-r-w-w-r-r(dTrp-dLys-dArg-dTrp-dArg-dArg-dTrp-dTrp-dArg-dArg), where all amino acids are D-type amino acids. The antimicrobial peptide provided by this invention exhibits good antimicrobial activity against a variety of pathogenic bacteria. This antimicrobial peptide can be synthesized using the Fmoc solid-phase chemical method, which is easy to synthesize and exhibits good in vivo antimicrobial activity. This antimicrobial peptide exhibits broad-spectrum killing activity against multidrug-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa, as well as standard strains of Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, methicillin-resistant Staphylococcus aureus, and Staphylococcus aureus. It has low hemolytic toxicity, and at low to medium concentrations (2 μg / mL to 32 μg / mL), the cell survival rate can reach more than 50%. It has no toxic effect on cells, good stability, strong operability, and low cost.
Need to check novelty before this filing date? Find Prior Art